Inst Diagnosti (INDISA) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Inst Diagnosti (INDISA) has a cash flow conversion efficiency ratio of 0.087x as of June 2023. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CL$8.87 Billion ≈ $9.92 Million USD) by net assets (CL$102.41 Billion ≈ $114.53 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Inst Diagnosti - Cash Flow Conversion Efficiency Trend (2014–2021)
This chart illustrates how Inst Diagnosti's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read total liabilities of Inst Diagnosti for a breakdown of total debt and financial obligations.
Inst Diagnosti Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Inst Diagnosti ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Shanghai Tianyong Engineering Co Ltd
SHG:603895
|
0.384x |
|
Leenos Corp
KQ:039980
|
-0.007x |
|
Guangdong New Grand Long Packing Co Ltd
SHE:002836
|
-0.088x |
|
Yunnan Metropolitan Real Estate Development Co Ltd
SHG:600239
|
0.112x |
|
EVS Broadcast Equipment SA
BR:EVS
|
-0.014x |
|
China Datang Corporation Renewable Power Co. Limited
F:DT7
|
0.045x |
|
Dalian Zhiyun Automation Co Ltd
SHE:300097
|
0.049x |
|
Beijing Transtrue Technology Inc
SHE:002771
|
0.002x |
Annual Cash Flow Conversion Efficiency for Inst Diagnosti (2014–2021)
The table below shows the annual cash flow conversion efficiency of Inst Diagnosti from 2014 to 2021. For the full company profile with market capitalisation and key ratios, see INDISA market cap.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2021-12-31 | CL$95.17 Billion ≈ $106.43 Million |
CL$14.83 Billion ≈ $16.59 Million |
0.156x | -8.57% |
| 2020-12-31 | CL$84.82 Billion ≈ $94.86 Million |
CL$14.46 Billion ≈ $16.17 Million |
0.170x | +30.98% |
| 2019-12-31 | CL$81.92 Billion ≈ $91.61 Million |
CL$10.66 Billion ≈ $11.92 Million |
0.130x | -32.89% |
| 2018-12-31 | CL$76.08 Billion ≈ $85.09 Million |
CL$14.75 Billion ≈ $16.50 Million |
0.194x | -10.15% |
| 2017-12-31 | CL$69.00 Billion ≈ $77.16 Million |
CL$14.89 Billion ≈ $16.65 Million |
0.216x | +17.62% |
| 2016-12-31 | CL$63.05 Billion ≈ $70.51 Million |
CL$11.57 Billion ≈ $12.94 Million |
0.183x | -30.86% |
| 2015-12-31 | CL$56.73 Billion ≈ $63.44 Million |
CL$15.05 Billion ≈ $16.84 Million |
0.265x | -2.00% |
| 2014-12-31 | CL$50.16 Billion ≈ $56.10 Million |
CL$13.58 Billion ≈ $15.19 Million |
0.271x | -- |
About Inst Diagnosti
Instituto de Diagnóstico S.A. provides health services in Chile. It offers patient information and exams instruction, and online services; specialties services; and outpatient services including urgency, laboratory, imaging, vaccination, blood bank, outpatient procedures, and reproductive medicine unit. The company also provides hospitalization services, such as maternity, adult and pediatric hos… Read more